Loading...
P3 Health Partners Inc.
PIII•NASDAQ
Healthcare
Medical - Care Facilities
$7.18
$-0.22(-2.93%)
P3 Health Partners Inc. (PIII) Financial Performance & Income Statement Overview
Review P3 Health Partners Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.48%
↑ 18.48%
Operating Income Growth
-86.23%
↓ 86.23%
Net Income Growth
-135.14%
↓ 135.14%
Operating Cash Flow Growth
-44.85%
↓ 44.85%
Operating Margin
-21.20%
↓ 21.20%
Gross Margin
-1.87%
↓ 1.87%
Net Profit Margin
-9.27%
↓ 9.27%
ROE
-129.07%
↓ 129.07%
ROIC
-113.76%
↓ 113.76%
P3 Health Partners Inc. (PIII) Income Statement & Financial Overview
Review P3 Health Partners Inc.'s (PIII) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $370.69M | $362.12M | $379.16M | $388.49M |
| Cost of Revenue | $768.77M | $0.00 | $365.17M | $403.60M |
| Gross Profit | -$398.08M | $362.12M | $13.99M | -$15.11M |
| Gross Profit Ratio | -$1.07 | $1.00 | $0.04 | -$0.04 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $31.83M | $27.35M | $27.02M | $27.72M |
| Operating Expenses | $509.19M | $469.11M | $45.32M | $28.72M |
| Total Costs & Expenses | $509.19M | $469.11M | $410.49M | $432.32M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $6.83M | $5.65M | $5.44M | $4.26M |
| Depreciation & Amortization | $21.15M | $21.67M | $21.69M | $21.54M |
| EBITDA | -$96.21M | -$79.14M | -$677000.00 | -$21.74M |
| EBITDA Ratio | -$0.26 | -$0.22 | -$0.002 | -$0.06 |
| Operating Income | -$138.50M | -$106.99M | -$31.33M | -$43.83M |
| Operating Income Ratio | -$0.37 | -$0.30 | -$0.08 | -$0.11 |
| Other Income/Expenses (Net) | $14.31M | $535000.00 | $3.53M | -$3.70M |
| Income Before Tax | -$124.20M | -$106.45M | -$27.81M | -$47.53M |
| Income Before Tax Ratio | -$0.34 | -$0.29 | -$0.07 | -$0.12 |
| Income Tax Expense | $4.95M | -$3.60M | $968000.00 | $2.07M |
| Net Income | -$58.62M | -$46.51M | -$12.02M | -$18.70M |
| Net Income Ratio | -$0.16 | -$0.13 | -$0.03 | -$0.05 |
| EPS | $0.63 | -$0.32 | -$0.15 | -$0.16 |
| Diluted EPS | $0.62 | -$0.31 | -$0.15 | -$0.16 |
| Weighted Avg Shares Outstanding | $3.25M | $161.89M | $136.60M | $118.89M |
| Weighted Avg Shares Outstanding (Diluted) | $3.25M | $164.70M | $141.08M | $118.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan